Zobrazeno 1 - 10
of 17
pro vyhledávání: '"BjøRn Naume"'
Autor:
Ohnstad, Hege, Borgen, Elin, Falk, Ragnhild, Lien, Tonje, Aaserud, Marit, Sveli, My, Kyte, Jon, Kristensen, Vessela, Geitvik, Gry, Schlichting, Ellen, Wist, Erik, SøRlie, Therese, Russnes, Hege, BjøRn Naume
Multivariate analysis of DDFS and BCSS for all patients, including PAM50 intrinsic subtypes. (DOC 49 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ccb1e424ee7caaabe2ebce0a10a85768
Autor:
Ohnstad, Hege, Borgen, Elin, Falk, Ragnhild, Lien, Tonje, Aaserud, Marit, Sveli, My, Kyte, Jon, Kristensen, Vessela, Geitvik, Gry, Schlichting, Ellen, Wist, Erik, SøRlie, Therese, Russnes, Hege, BjøRn Naume
Multivariate analysis of DDFS and BCSS for all patients, including PAM50 intrinsic subtypes. (DOC 49 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07058cc0c1c925eb3ee2bcc3317dc2cb
Autor:
Borgen, Elin, Rypdal, Maria, Sosa, Maria, Renolen, Anne, Schlichting, Ellen, LøNning, Per, Synnestvedt, Marit, Aguirre-Ghiso, Julio, BjøRn Naume
Figure S6. (A) Survival analyses (time to systemic relapse/breast cancer death) in relation to NR2F1 profile at last DIF DTC-positive BMA, restricted to those with Ki67 DTC analysis available (only patients being nonmetastatic at last DIF DTC-positiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d16d3e3039af3f749f42cd3d0f53772
Autor:
Borgen, Elin, Rypdal, Maria, Sosa, Maria, Renolen, Anne, Schlichting, Ellen, LøNning, Per, Synnestvedt, Marit, Aguirre-Ghiso, Julio, BjøRn Naume
Table S2. Overview of patient material and DTC results. (DOCX 34 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05cc1d589c6216da9f37387b72bed070
Autor:
Borgen, Elin, Rypdal, Maria, Sosa, Maria, Renolen, Anne, Schlichting, Ellen, LøNning, Per, Synnestvedt, Marit, Aguirre-Ghiso, Julio, BjøRn Naume
Table S4. Overview of received treatment between the two BM aspiration time points for the patients presented in Fig. 3. (DOCX 33 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e57a7345a042442536e27122539d8a2
Autor:
Borgen, Elin, Rypdal, Maria, Sosa, Maria, Renolen, Anne, Schlichting, Ellen, LøNning, Per, Synnestvedt, Marit, Aguirre-Ghiso, Julio, BjøRn Naume
Figure S6. (A) Survival analyses (time to systemic relapse/breast cancer death) in relation to NR2F1 profile at last DIF DTC-positive BMA, restricted to those with Ki67 DTC analysis available (only patients being nonmetastatic at last DIF DTC-positiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e5ad1fbeafb40a61ce314ae51d42454
Autor:
Borgen, Elin, Rypdal, Maria, Sosa, Maria, Renolen, Anne, Schlichting, Ellen, LøNning, Per, Synnestvedt, Marit, Aguirre-Ghiso, Julio, BjøRn Naume
Figure S3. Serial BM samples: number of DTCs detected in the original DTC analysis (APAAP-ICC technique). (PPTX 128 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2427ccaff39751521485644c95dadad1
Autor:
Borgen, Elin, Rypdal, Maria, Sosa, Maria, Renolen, Anne, Schlichting, Ellen, LøNning, Per, Synnestvedt, Marit, Aguirre-Ghiso, Julio, BjøRn Naume
Table S5. Additional results from the serial DTC analyses on samples presented in Fig. 3b and c (in the same order). (DOCX 39 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab96794a790e59bf1bba5b452f787bbf
Autor:
Borgen, Elin, Rypdal, Maria, Sosa, Maria, Renolen, Anne, Schlichting, Ellen, LøNning, Per, Synnestvedt, Marit, Aguirre-Ghiso, Julio, BjøRn Naume
Figure S3. Serial BM samples: number of DTCs detected in the original DTC analysis (APAAP-ICC technique). (PPTX 128 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4cd5dd4a5a557fafd6472ab46dc04e8
Autor:
Borgen, Elin, Rypdal, Maria, Sosa, Maria, Renolen, Anne, Schlichting, Ellen, LøNning, Per, Synnestvedt, Marit, Aguirre-Ghiso, Julio, BjøRn Naume
Figure S5. Survival analyses according to NR2F1 and Ki67 DTC profiles of patients being nonmetastatic at the time of last DIF DTC-positive BMA, having no subsequent BM analyzed, and no chemotherapy after last BMA. (PPTX 120 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73d097386af4fef2a6d26c0d6a6e2bcf